Targeting sgRNA N secondary structure as a way of inhibiting SARS-CoV-2 replication.
Baliga-Gil A, Soszynska-Jozwiak M, Ruszkowska A, Szczesniak I, Kierzek R, Ciechanowska M, Trybus M, Jackowiak P, Peterson JM, Moss WN, Kierzek E.
Baliga-Gil A, et al. Among authors: kierzek r.
Antiviral Res. 2024 Aug;228:105946. doi: 10.1016/j.antiviral.2024.105946. Epub 2024 Jun 24.
Antiviral Res. 2024.
PMID: 38925369
Free article.